{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:54:08Z","timestamp":1794020048736,"version":"4.8.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vanishing white matter disease (VWMD; OMIM 603896), also known as childhood ataxia with central nervous system hypomyelination (CACH), is a rare autosomal recessive leukodystrophy caused by pathogenic variants in the EIF2B gene family (EIF2B1\u2013EIF2B5). Clinical manifestations are highly heterogeneous, with onset ranging from fetal life to adulthood; adult-onset cases remain relatively rare and often present with atypical symptoms. Brain magnetic resonance imaging (MRI) and genetic testing are pivotal for diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>We report a 32-year-old Chinese female with adult-onset VWMD characterized by intermittent headaches, progressive cognitive decline, menstrual irregularities, and hearing loss. Cranial MRI with diffusion-weighted imaging (DWI) revealed symmetrical periventricular and centrum semiovale white matter abnormalities. Whole-exome sequencing (WES) identified a homozygous missense variant in the EIF2B5 gene, formatted per Human Genome Variation Society (HGVS) guidelines as NM_001414.4:c.185A&amp;gt;T (p.Asp62Val). This variant was previously documented exclusively in a pediatric patient, representing the first report in an adult.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our case expands the phenotypic and age-related spectrum of EIF2B5-associated VWMD, highlighting that the c.185A&amp;gt;T variant is capable of manifesting in adulthood with non-classical features (e.g., headache as the initial symptom). Prior studies have confirmed that this variant impairs EIF2B complex function, which reinforces its pathogenic role in disrupting the integrated stress response (ISR) and maintaining white matter homeostasis. A literature review of 99 genetically confirmed adult-onset VWMD cases further underscores genotype\u2013phenotype correlations: EIF2B5 is the most frequently mutated subunit in adult patients, with cerebellar ataxia, cognitive decline, and psychiatric symptoms as the predominant initial manifestations. Female patients often present with premature ovarian failure, a key diagnostic hallmark. Early genetic testing is crucial for definitive diagnosis, prenatal counseling, and symptomatic management. Notably, this study has limitations, including the lack of investigation into gene-gene interactions\u2014factors that may modulate disease severity and phenotypic variability\u2014and the unavailability of parental genetic data to fully validate zygosity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1739328","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T22:10:18Z","timestamp":1769983818000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Adult-onset vanishing white matter disease caused by the EIF2B5 c.185A&gt;T (p.Asp62Val) variant"],"prefix":"10.3389","volume":"17","author":[{"given":"Jie","family":"Zhou","sequence":"first","affiliation":[{"name":"Clinical College of Ningxia Medical University","place":["Yinchuan, Ningxia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurophysiology,General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhu","sequence":"additional","affiliation":[{"name":"Clinical College of Ningxia Medical University","place":["Yinchuan, Ningxia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/acn3.50826","article-title":"Vanishing white matter: deregulated integrated stress response as therapy target","volume":"6","author":"Abbink","year":"2019","journal-title":"Ann. Clinical Translational Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1007\/s00415-023-11762-7","article-title":"Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients","volume":"270","author":"Benzoni","year":"2023","journal-title":"J. Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jns.2011.10.021","article-title":"Late onset Vanishing white matter disease presenting with learning difficulties","volume":"314","author":"Dam\u00e1sio","year":"2012","journal-title":"J. Neurological Sciences"},{"key":"B4","doi-asserted-by":"publisher","first-page":"729777","DOI":"10.3389\/fgene.2021.729777","article-title":"Correlation between genotype and age of onset in leukoencephalopathy with vanishing white matter","volume":"12","author":"Deng","year":"2021","journal-title":"Front. Genetics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e64497","DOI":"10.7759\/cureus.64497","article-title":"Ovarioleukodystrophy due to EIF2B genes: systematic review and case report","volume":"16","author":"Escobar-Pacheco","year":"2024","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/375404","article-title":"Ovarian failure related to eukaryotic initiation factor 2B mutations","volume":"72","author":"Fogli","year":"2003","journal-title":"Am. Journal Human Genetics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ana.25287","article-title":"Natural history of vanishing white matter","volume":"84","author":"Hamilton","year":"2018","journal-title":"Ann. Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12888-020-02551-x","article-title":"The disappearance of white matter in an adult-onset disease: a case report","volume":"20","author":"Ho","year":"2020","journal-title":"BMC Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e56319","DOI":"10.7554\/eLife.56319","article-title":"Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response","volume":"9","author":"Keefe","year":"2020","journal-title":"eLife"},{"key":"B10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng764","article-title":"Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter","volume":"29","author":"Leegwater","year":"2001","journal-title":"Nat. Genetics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/jhg.2011.9","article-title":"Functional analysis of recently identified mutations in eukaryotic translation initiation factor 2B\u025b (eIF2B\u025b) identified in Chinese patients with Vanishing white matter disease","volume":"56","author":"Leng","year":"2011","journal-title":"J. Human Genetics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jamaneurol.2016.2229","article-title":"Analysis of mutations in AARS2 in a series of CSF1R-Negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"73","author":"Lynch","year":"2016","journal-title":"JAMA Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"CD015824","DOI":"10.1002\/14651858.CD015824.pub2","article-title":"Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension","volume":"8","author":"Oba","year":"2025","journal-title":"Cochrane Database Systematic Reviews"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1007\/s10072-022-06011-0","article-title":"Genotypic and phenotypic characteristics of juvenile\/adult onset vanishing white matter: a series of 14 Chinese patients","volume":"43","author":"Ren","year":"2022","journal-title":"Neurol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s004010051016","article-title":"Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases","volume":"97","author":"Rodriguez","year":"1999","journal-title":"Acta Neuropathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"SS181","DOI":"10.29271\/jcpsp.2022.Supp0.SS181","article-title":"Adult Vanishing white matter disease with a novel EIF2B4 mutation","volume":"32","author":"Su","year":"2022","journal-title":"J. Coll. Physicians Surgeons--Pakistan JCPSP"},{"key":"B17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/wnl.48.4.845","article-title":"A new leukoencephalopathy with vanishing white matter","volume":"48","author":"van der Knaap","year":"1997","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12883-019-1429-9","article-title":"Adult-onset Vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia","volume":"19","author":"Wei","year":"2019","journal-title":"BMC Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s10072-021-05710-4","article-title":"Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis","volume":"43","author":"Xu","year":"2021","journal-title":"Neurol. Sci."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1739328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:28:26Z","timestamp":1771925306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1739328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":19,"alternative-id":["10.3389\/fgene.2026.1739328"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1739328","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1739328"}}